BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17884843)

  • 1. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
    Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
    Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression of GDP-L-fucose-synthesizing enzymes, GDP-fucose transporter and fucosyltransferase VII.
    Niittymäki J; Mattila P; Renkonen R
    APMIS; 2006; 114(7-8):539-48. PubMed ID: 16907860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer.
    Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
    Histopathology; 2013 Aug; 63(2):174-86. PubMed ID: 23730929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
    Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
    J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
    Noda K; Miyoshi E; Uozumi N; Yanagidani S; Ikeda Y; Gao C; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Hayashi N; Hori M; Taniguchi N
    Hepatology; 1998 Oct; 28(4):944-52. PubMed ID: 9755230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
    Nakagawa T; Moriwaki K; Terao N; Nakagawa T; Miyamoto Y; Kamada Y; Miyoshi E
    J Proteome Res; 2012 May; 11(5):2798-806. PubMed ID: 22483194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological function of fucosylation in cancer biology.
    Miyoshi E; Moriwaki K; Nakagawa T
    J Biochem; 2008 Jun; 143(6):725-9. PubMed ID: 18218651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells.
    Ohyama C; Smith PL; Angata K; Fukuda MN; Lowe JB; Fukuda M
    J Biol Chem; 1998 Jun; 273(23):14582-7. PubMed ID: 9603974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
    Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
    Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of human alpha-1,3-fucosyltransferase V: glycosidic cleavage occurs prior to nucleophilic attack.
    Murray BW; Wittmann V; Burkart MD; Hung SC; Wong CH
    Biochemistry; 1997 Jan; 36(4):823-31. PubMed ID: 9020780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of GDP-fucose level for generating proteins with reduced rate of fucosylation (WO2010141855).
    Taupin P
    Expert Opin Ther Pat; 2011 Sep; 21(9):1497-9. PubMed ID: 21548846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma.
    Wang Y; Huang D; Chen KY; Cui M; Wang W; Huang X; Awadellah A; Li Q; Friedman A; Xin WW; Di Martino L; Cominelli F; Miron A; Chan R; Fox JG; Xu Y; Shen X; Kalady MF; Markowitz S; Maillard I; Lowe JB; Xin W; Zhou L
    Gastroenterology; 2017 Jan; 152(1):193-205.e10. PubMed ID: 27639802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
    Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Nakagawa T; Matsumoto H; Asahi M; Koyama N; Miyoshi E
    Biochem Biophys Res Commun; 2008 Dec; 377(3):792-6. PubMed ID: 18951869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor SP1 regulates haptoglobin fucosylation via induction of GDP-fucose transporter 1 in the hepatoma cell line HepG2.
    Kondo J; Sakata N; Morishita K; Hayashibara A; Sakon D; Takamatsu S; Asakura N; Suzuki T; Miyoshi E
    Biochem Biophys Rep; 2022 Dec; 32():101372. PubMed ID: 36313594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of caveolin-1 gene in hepatitis B-related hepatocellular carcinoma and the clinical significance thereof].
    Yan J; Lu Q; Cai L; Li XW; Dong JH
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3272-4. PubMed ID: 19159553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
    Moriwaki K; Noda K; Furukawa Y; Ohshima K; Uchiyama A; Nakagawa T; Taniguchi N; Daigo Y; Nakamura Y; Hayashi N; Miyoshi E
    Gastroenterology; 2009 Jul; 137(1):188-98, 198.e1-2. PubMed ID: 19361506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.